Actively Recruiting
Topical Oxybutynin for Treatment of Hyperidrosis: Local or Systemic Effect?
Led by Samantha Rodrigues Camargo Neves de Moura · Updated on 2024-05-28
17
Participants Needed
1
Research Sites
100 weeks
Total Duration
On this page
Sponsors
S
Samantha Rodrigues Camargo Neves de Moura
Lead Sponsor
S
Science Valley Research Institute
Collaborating Sponsor
AI-Summary
What this Trial Is About
The TODAY trial is a study to evaluate the efficacy and safety of topical oxybutynin deodorant for use in patients with axillary hyperhidrosis.
CONDITIONS
Official Title
Topical Oxybutynin for Treatment of Hyperidrosis: Local or Systemic Effect?
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 years and older and 45 years and younger
- Patients not treated with any drug or treatment for hyperhidrosis for at least 30 days
You will not qualify if you...
- Patients allergic to oxybutynin hydrochloride
- Patients treated with any drug or treatment for hyperhidrosis within the last 30 days
- Patients with menopausal symptoms
- Patients with skin lesions in the armpit area
- Pregnant women or women who might become pregnant without contraceptive measures and a negative pregnancy test
- Patients currently contagious with COVID-19 (PCR positive)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Irmandade da Santa Casa de Misericórdia de São Paulo
São Paulo, São Paulo, Brazil, 01.223-001
Actively Recruiting
Research Team
S
Samantha Moura, MD
CONTACT
L
Leandro Agati, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here